An uncommon presentation of Kikuchi Fujimoto disease: a case report with literature review

BMC Research Notes

Bidur Prasad Osti¹  Sushna Maharjan¹  Jiwan Kshetri¹  Mamta Tiwari¹  Sabin Ranabhat¹ 

[1] Department of Pathology, Chitwan Medical College (CMC) Teaching Hospital, Bharatpur-10, Chitwan, Nepal

关键词: Nepal;    Thrombocytopenia;    Lymphadenitis;    Fujimoto;    Kikuchi;   

Others  :  1229975
DOI  :  10.1186/s13104-015-1460-x

 received in 2014-12-16, accepted in 2015-09-21,  发布年份 2015

【 摘 要 】

Background

Kikuchi–Fujimoto disease is so named because Kikuchi and Fujimoto were the first scientists to describe it in Japan in 1972. Although the disease has been reported from all over the world and more so from Asia, it is rare. To date only eight cases have been reported from Nepal. Cervical lymphadenopathy, fever and raised Erythrocyte Sedimentation Rate are usual presenting features of this disease. We describe a case which presented with thrombocytopenia and axillary lymphadenopathy in addition to the usual features. Out of the total eight cases that have been reported from Nepal so far, no patients had thrombocytopenia and only one patient had axillary lymphadenopathy.

Case presentation

A 24-year-old Nepali female presented with a 3-week history of low-grade fever, headache, and painful, discrete, unilateral left-sided cervical and axillary lymphadenopathy. Among the multitude of tests that were carried out, Erythrocyte Sedimentation Rate was raised and there was thrombocytopenia while other tests were normal. Painful lymphadenopathy pointed to bacterial lymphadenitis while chronic low-grade fever suggested tuberculosis. A cervical lymph node was excised for histopathological examination to reach an accurate diagnosis. On the basis of pathognomonic features viz., paracortical foci composed of various types of histiocytes including crescentic type in the background of abundant apoptotic karyorrhectic debris, a diagnosis of Kikuchi–Fujimoto disease was made. On follow-up evaluation after 6 weeks, the patient had no systemic symptoms, enlarged lymph nodes had regressed in size significantly, and Erythrocyte Sedimentation Rate and platelet count had become normal.

Conclusion

Kikuchi–Fujimoto disease should be kept in the differential diagnosis of lymphadenopathy in young patients, female or male even in tuberculosis-endemic countries and even in patients who have unusual features; for example thrombocytopenia and involvement of axillary lymph nodes in addition to cervical lymph nodes as in this case.

【 授权许可】

   
2015 Ranabhat et al.

【 图 表 】

Fig.1.

Fig.2.

【 参考文献 】

• [1]Deaver D, Horna P, Cualing H, Sokol L: Pathogenesis, diagnosis and management of Kikuchi–Fujimoto disease. Cancer Control 2014, 21(4):313-321.
• [2]Rosado FG, Tang YW, Hasserjian RP, McClain CM, Wang B, Mosse CA: Kikuchi–Fujimoto lymphadenitis: role of parvovirus B-19, Epstein–Barr virus, human herpesvirus 6, and human herpesvirus 8. Hum Pathol 2013, 44:255-259.
• [3]Cheng CY, Sheng WH, Lo YC, Chung CS, Chen YC, Chang SC: Clinical presentations, laboratory results and outcomes of patients with Kikuchi’s disease: emphasis on the association between recurrent Kikuchi’s disease and autoimmune diseases. J Microbiol Immunol Infect 2010, 43(5):366-371.
• [4]Zou CC, Zhao ZY, Liang L: Childhood Kikuchi–Fujimoto disease. Indian J Pediatr 2009, 76(9):959-962.
• [5]Bakhshi GD, Shenoy SS, Jadhav KV, Tayade MB, Pawar DS, Tejaswini D, Singh AK: Kikuchi’s disease: a case report. IJMAS 2014, 3(1):10-15.
• [6]Hutchinson CB, Wang E: Kikuchi–Fujimoto disease. Arch Pathol Lab Med 2010, 134:289-293.
• [7]Adhikari RC, Sayami G, Lee MC, Basnet RB, Shrestha PK, Shrestha HG: Kikuchi–Fujimoto disease in Nepal: a study of 6 cases. Arch Pathol Lab Med 2003, 127:1345-1348.
• [8]Graham LE: Kikuchi–Fujimoto disease and peripheral arthritis: a first! Ann Rheum Dis 2002, 61:475.
• [9]Baskota DK: Kikuchi–Fujimoto disease: a rare cause of cervical lymphadenopathy. Nepal Med Coll J 2006, 8(1):63-64.
• [10]Bosch X, Guilabert A, Miquel R, Campo E: Enigmatic Kikuchi–Fujimoto disease: a comprehensive review. Am J Clin Pathol 2004, 122:141-152.
• [11]Bagri PK, Beniwal S, Jakhar SL, Kapoor A: Kikuchi–Fujimoto disease: a diagnostic and therapeutic challenge. Clin Cancer Investig J 2014, 3:254-256.
• [12]Vani BR, Geethamala K, Murthy VS: Kikuchi Fujimoto disease: a clinical and cytohistopathological studies of four cases with brief review of literature. IJHAS 2014, 3(2):137.
• [13]Chatterjee SS, Sengupta K, Mukhopadhyay P, Bandyopadhyay D, Chaudhury SR: A case of Kikuchi–Fujimoto disease. JIACM 2014, 15(3–4):224-226.
• [14]Famularo G, Giustiniani MC, Marasco A, Minisola G, Nicotra GC, Simone CD: Kikuchi Fujimoto lymphadenitis: case report and literature review. Am J Hematol 2003, 74:60-63.
• [15]Ingle SB, Hinge CR, Chopra S: A rare case of Kikuchi’s disease—case report. Indian J Med Case Rep 2012, 1(1):1-3.
• [16]Sudhakar MK, Sathyamurthy P, Indhumathi E, Rajendran A, Vivek B: Kikuchi’s disease: a case report from South India. IJCRI 2011, 2(2):15-18.
• [17]Cheng CY, Sheng WH, Lo YC, Chung CS, Chen YC, Chang SC: Clinical presentations, laboratory results and outcomes of patients with Kikuchi’s disease: emphasis on the association between recurrent Kikuchi’s disease and autoimmune diseases. J Microbiol Immunol Infect 2010, 43(5):366-371.
• [18]Kwon SY, Kim TK, Kim YS, Lee KY, Lee NJ, Seol HY: CT findings in Kikuchi disease: analysis of 96 cases. Am J Neuroradiol 2004, 25:1099-1102.
• [19]Massachusetts Department of Public Health Bureau of Infectious Disease. Prevention, Response and Services Division of Tuberculosis Prevention and Control: countries with high rates of tuberculosis (TB) ±TB endemic countries. http://www.mass.gov/eohhs/docs/dph/cdc/tb/endemic-country-list.pdf. Accessed Nov 11 2014.